AOCI at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s AOCI?
- Oric Pharmaceuticals, Inc. (ORIC) reported AOCI of -$290K in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s AOCI changed year-over-year?
- Oric Pharmaceuticals, Inc.'s AOCI decreased by 238.8% year-over-year, from $209K to -$290K.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s AOCI?
- Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s AOCI has grown at a 90.9% compound annual growth rate (CAGR), from -$31K to $786K.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.